USPTO Patents Application 09993647

ElcwilUlllw nwlMlUWlcUMclllclll newel IJ 1

EFSID:

7718203

Application Number:

09993647

International Application Number:

Confirmation Number:

1010

Title of Invention:

omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

First Named Inventor/Applicant Name:

Bernd Riedl

Customer Number:

23599

Filer:

Csaba Henter/Caitlin Sickler

Filer Authorized By:

Csaba Henter

Attorney Docket Number:

BAYER 18A

Receipt Date:

01-JUN-2010

Filing Date:

27-NOV-2001

Time Stamp:

13:41:39

Application Type:

Utility under 35 USC 111(a)

Payment information:

Submitted with Payment

no

File Listing:

Document
Number

Document Description

File Name

FileSize(Bytes)/
Message Digest

Multi
Part /.zip

Pages
(if appl.)

1

NPL Documents

P47-CHOW-
MeasurementofMAPkinaseactiv
ation.pdf

190254

fdfdc5ac656e3eb8345964474554df54c272

am

no

7

Warnings:

Information:

2

NPL Documents

P47a-Christensen-et-al-MI-
Cancer-Ther-v4-n6-p938.pdf

2078285

no

10

8fe3ac6353fe6055f662f58b647550db1cf6c
332

Warnings:

Information:

3

NPL Documents

P47b-

ChuetalCardiotoxicityAssociate
dwithTyrosineKinase.PDF

824576

no

9

0b14444245e1 5fdf2e1 284003b68a4e0409
deadb

Warnings:

Information:

4

NPL Documents

P48-CHUSTECKAETAL-
BortezomibSorafenibThyroidCa
ncer.pdf

121562

no

2

e0c3da562b2eadb0c9502e26baf8489286
88b6

Warnings:

Information:

5

NPL Documents

P49-

ClarkSafetyandPharmacokineti
csoftheDualActionRafKinasean
d.pdf

1034920

no

9

C2eaf2ee4a6b212855a63595dc5c705ba2d
4a2a1

Warnings:

Information:

6

NPL Documents

P50-

COPERETCHRISTOPHEETALASI
MPLEANDEFFCIENTMETHODFO
RTHEPREPARATIONOF.PDF

246666

no

4

35fca5e45b2ed4f201526da7d439399eb46
b8989

Warnings:

Information:

7

NPL Documents

P51-Cortes-
TargetingTheMicrotubuleslnBr
eastCancerBeyondTaxanes.pdf

1081233

no

11

b69de9169fe3fa10ad6cd8d2a22785a3a35
25d48

Warnings:

Information:

8

NPL Documents

P52-Craig-
Mechanismsofdrugrelease.pdf

741123

no

14

478ed22f72525497059e99f1497d8714776
99304

Warnings:

Information:

9

NPL Documents

P53a-

CrumplnhibitionofRafkinaseAM
Lpdf

129960

no

2

f7afec875758c734aa4383c5be17b8479616
4f0b

Warnings:

Information:

10

NPL Documents

P53-CRAS-
TreatmentNewbornRats.pdf

492222

no

9

01 93b5ff56a34ca7ec8f94e86cbedc351 5fce
038

Warnings:

Information:

11

NPL Documents

P54-

CunninghametalPhaselTrailHR
AS.pdf

529224

no

7

e9014e4c3c26a1c444cf6cl3bfa7eee326896
41 4e

Warnings:

Information:

12

NPL Documents

P55-

DansonlmprovingOutcomesin
AdvancedMalignantMelanoma.
pdf

859338

no

11

9cc2dcc7f02852a3f5f9fd1 1 1ffd4812a1 650!
3a

Warnings:

Information:

13

NPL Documents

P56-

DASMAHAPATRAETALINVITRO
COMBINATIONTREATMENTWIT
H.pdf

572714

no

11

512143e72fa41cd8062701ed0b32ce5370a
f8a7

Warnings:

Information:

14

NPL Documents

P57-

DaumThelnsandOutsofRafKina
ses.pdf

923597

no

7

b8dd50c7c5aaa180ac3cbf8bc2292fec15b7
9e90

Warnings:

Information:

15

NPL Documents

P58-

DAYANETALTERTIARYAMINEOX
IDATIONUSING.PDF

272220

no

4

3db4be570421b9423994357a8c0da85c33
7be00f

Warnings:

Information:

16

NPL Documents

P59-

DeGrendeleActivityoftheRafKin
aselnhibitorBAY43-9006inPatie
ntswithAdvancedSolidTumors.

222928

no

3

dcaa5b0b3ecc0dd5eea690e754c997c58ee
d972a

Warnings:

Information:

17

NPL Documents

P59a-

DehtlingGrosseOnkologie-
Pipeline.pdf

124146

no

2

98b96eeee5ddb67e317cbc55f5e77f1523f9
d5d8

Warnings:

Information:

18

NPL Documents

P60-

DENNYWILLIAMAPRODRUGSTR
ATEFIESINCANCERTHERAPY.
PDF

1565025

no

19

a2ec91172957676af6dcde65d7bff33e0462
73c0

Warnings:

Information:

19

NPL Documents

P60a-

DeVitaetalElevatedPreopertives
VEGF.pdf

119665

no

9

7c4f005633398386817ef069fec30d68d540
ace7

Warnings:

Information:

Total Files Size (in bytes)

12129658

This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
Post Card, as described in MPEP 503.

New Applications Under 35 U.S.C. 1 1 1

If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
1 .53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1 .54) will be issued in due course and the date shown on this
Acknowledgement Receipt will establish the filing date of the application.

National Stage of an International Application under 35 U.S.C. 371

If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.

New International Application Filed with the USPTO as a Receiving Office

If a new international application is being filed and the international application includes the necessary components for
an international filing date (see PCT Article 1 1 and MPEP 1 81 0), a Notification of the International Application Number
and of the International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
the application.